Whoops, your site does not have a menu!

Search for cure against the lethal disease ALS boosted by new investor

Home
news
Search for cure against the lethal disease ALS boosted by new investor

Search for cure against the lethal disease ALS boosted by new investor

Orphazyme closes a €14 million Series B Extension

Orphazyme, joint portfolio company of ALS Investment Fund and LSP, raises approximately €80 million in oversubscribed IPO

Recent Posts

Orphazyme, joint portfolio company of ALS Investment Fund and LSP, raises approximately €80 million in oversubscribed IPO
Search for cure against the lethal disease ALS boosted by new investor
Orphazyme closes a €14 million Series B Extension
Amylyx Pharmaceuticals Receives FDA Orphan Drug Designation for AMX0035 for the Treatment of Amyotrophic Lateral Sclerosis
Project ALS and Amylyx Enter Collaboration to Test AMX0035